Skip to main content Accessibility help
×
Home

Antidepressants; what’s the beef?

  • Guy M. Goodwin (a1) and David Nutt (a2)
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Antidepressants; what’s the beef?
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Antidepressants; what’s the beef?
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Antidepressants; what’s the beef?
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

Corresponding author

Author for correspondence: Guy M. Goodwin, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK; E-mail: guy.goodwin@psych.ox.ac.uk

References

Hide All
1. Jakobsen, JC, Katakam, KK, Schou, A, Hellmuth, SG, Stallknecht, SE Leth-Moller, K et al. (2017) Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry 17, 58.
2. Hieronymus, F, Lisinski, A, Naslund, J Eriksson, E ( 2018) Multiple possible inaccuracies cast doubt on a recent report suggesting selective serotonin reuptake inhibitors to be toxic and ineffective. Acta Neuropsychiatr. 30, 244250.
3. Katakam, KK, Sethi, NJ, Jakobsen, JC Gluud, C (2018) Great boast, small roast on effects of selective serotonin reuptake inhibitors: response to a critique of our systematic review. Acta Neuropsychiatr 30, 251265.
4. Jakobsen, JC, Katakam, KK, Schou, A, Hellmuth, SG, Stallknecht, SE Leth-Moller, K et al. (2017) Erratum to: selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry 17, 162.
5. Thase, ME, Larsen, KG Kennedy, SH (2011) Assessing the ‘true’ effect of active antidepressant therapy v. placebo in major depressive disorder: use of a mixture model. Br J Psychiatry 199, 501507.
6. Melander, H, Salmonson, T, Abadie, E van Zwieten-Boot, B (2008) A regulatory Apologia--a review of placebo-controlled studies in regulatory submissions of new-generation antidepressants. Eur Neuropsychopharmacol 18, 623627.
7. Hieronymus, F, Emilsson, JF, Nilsson, S Eriksson, E (2016) Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psychiatry 21, 523530.
8. Leucht, S, Hierl, S, Kissling, W, Dold, M Davis, JM (2012) Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry 200, 97106.
9. Geddes, JR, Carney, SM, Davies, C, Furukawa, TA, Kupfer, DJ Frank, E et al. (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361, 653661.
10. Cipriani, A, Furukawa, TA, Salanti, G, Chaimani, A, Atkinson, LZ Ogawa, Y et al. (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391, 13571366.

Antidepressants; what’s the beef?

  • Guy M. Goodwin (a1) and David Nutt (a2)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed